MYLA CLINIC PATCH 3.2.0 CD Product Usage: MYLA is a computer application (Middleware) based on Web 2.0 technology which: Interfaces between the instruments connected to the application and the LIS(s) (Laboratory Information System(s)).
Published December 23, 2015 · Recall initiated: November 3, 2015
Summary
FDA records medical device Class II recall Z-0425-2016, published December 23, 2015 and initiated November 3, 2015. Recalling firm: bioMerieux, Inc.; Status: Terminated; Reported quantity: 626 systems in total; Lot: REF # 414518, Serial number/Software version V3.2 CLI. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
MYLA® software connected to a Laboratory Information System (LIS) and a VITEK® 2 system has the potential to link a test result to an incorrect patient record with the same specimen ID.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- bioMerieux, Inc.
- Distributor
- Worldwide Distribution - US Nationwide in the states of: AK, AL, AR, AZ, CA, CT, FL, GA, HI, IA, ID, IL, IN, KS, LA, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and countries of: Foreign accounts: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, France, Germany, Greece, Hungary, India, Italy, Japan, Korea, Netherlands, Poland, Portugal, Russia, Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, Angola, Puerto Rico, Republic of Belarus, Republic of Belarus, Benin, Bosnia, Brunei, Bulgaria, Burkina Faso, Cambodia, Cameroon, Chad, Democratic Republic of Congo, Costa Rica, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Gabon, Guam, Guatemala, Guatemala, Guinea, Honduras, Indonesia, Iraq, Israel, Ivory Coast, Kazakhstan, Kenya, Kenya, Kuwait, Laos, Latvia, Lebanon, Libya, Lithuania, Malaysia, Malaysia, Mali, Portugal, Myanmar, Managua, Niger, Nigeria, Palestine, Philippines, Philippines, Qatar, Kingdom of Saudi Arabia, Senegal, Serbia, Slovakia, Togo, Tunisia, Ukraine, UAE, Vietnam, Vietnam, Ivory Coast and Zimbabwe.
- Lot
- REF # 414518, Serial number/Software version V3.2 CLI
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITEK 2 Systems and VITEK 2 with MYLA.May 18, 2022
- FDAVIDAS RUB IgG (RBG), REF 30226January 5, 2022
- FDAVITEK® 2 Systems Software Version 9.01 Update Kit.December 26, 2018
- FDABACT/ALERT VIRTUO system, B Unit, with Version R2.0 Firmware Product Usage: The BacT/ALERT VIRTU MicrobialOctober 31, 2018
- FDAGE Healthcare Optima IGS 320. Product Usage: The angiographic X-ray systems are indicated for use for patientsDecember 23, 2015
- FDAMYLA MASTER DVD 3.2 CLI DL380 Product Usage: MYLA is a computer application (Middleware) based on Web 2.0December 23, 2015
Questions about this recall
Was MYLA CLINIC PATCH 3.2.0 CD Product Usage: MYLA is a computer application (Middleware) based on Web 2.0 technology which: Interfaces between the instruments connected to the application and the LIS(s) (Laboratory Information System(s)). recalled?
Yes. FDA published recall Z-0425-2016 on December 23, 2015. Reported hazard: MYLA® software connected to a Laboratory Information System (LIS) and a VITEK® 2 system has the potential to link a test result to an incorrect patient record with the same specimen ID.
What should I do if I have this product?
Voluntary: Firm initiated · Letter